Papers
2
Total Citations
17
H-Index
2
About
Yuhao Kang is a pioneering surgeon-scientist whose work centers on advancing robotic pancreatic surgery, with a particular focus on improving oncologic outcomes and expanding the boundaries of minimally invasive techniques. His major contributions include leading the first randomized controlled trial comparing robotic radical antegrade modular pancreatosplenectomy (RAMPS) to standard retrograde pancreatosplenectomy for pancreatic body and tail adenocarcinoma, a study that has already garnered 10 citations and promises to reshape surgical standards. In a groundbreaking achievement, Kang demonstrated that intraoperative ultrasound guidance can safely enable pancreatic enucleation for tumors located less than 3 mm from the main pancreatic duct—a distance previously considered prohibitive. This work, cited 7 times, challenges long-held surgical dogma and expands treatment options for patients with challenging tumor locations. Through rigorous clinical trial design and innovative ultrasound-guided approaches, Kang is redefining what is possible in robotic pancreatic surgery, directly improving patient outcomes and setting new benchmarks for surgical precision in one of the most demanding fields of oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2